ID: ALA3092112

Max Phase: Preclinical

Molecular Formula: C12H9BrO2

Molecular Weight: 265.11

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC1=C(Br)C(=O)c2ccccc2C1=O

Standard InChI:  InChI=1S/C12H9BrO2/c1-2-7-10(13)12(15)9-6-4-3-5-8(9)11(7)14/h3-6H,2H2,1H3

Standard InChI Key:  DMDUKOTWUUJQSN-UHFFFAOYSA-N

Associated Targets(non-human)

NAD(P)H dehydrogenase [quinone] 1 3 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 265.11Molecular Weight (Monoisotopic): 263.9786AlogP: 3.12#Rotatable Bonds: 1
Polar Surface Area: 34.14Molecular Species: HBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.89CX LogD: 2.89
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.78Np Likeness Score: 0.31

References

1. Nasiri HR, Madej MG, Panisch R, Lafontaine M, Bats JW, Lancaster CR, Schwalbe H..  (2013)  Design, synthesis, and biological testing of novel naphthoquinones as substrate-based inhibitors of the quinol/fumarate reductase from Wolinella succinogenes.,  56  (23): [PMID:24251984] [10.1021/jm400978u]

Source